Artis Ventures — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
New York, US
Board seatStuart Peterson· per SEC Form D · $33M raise · filed Sep 2025
Co-investorsACME Capital
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US
Max Mumbach(Founding Scientist, Target Discovery)Jeffrey Verboon(Founding Scientist, Computational Biology)Ansu Satpathy(Founder)Kevin Parker, PhD(Chief Executive Officer, Board Director; co-founder)Ansuman Satpathy, MD, PhD(Co-founder; Board Director)Howard Chang(Co-founder)
Co-investors8VCAndreessen HorowitzGlobal BioAccess FundHAWKTAILPfizer Venture InvestmentsWing+6 more
Conceivable builds AURA, a robotic automation platform that automates manual IVF laboratory procedures using physical AI, aiming to increase accessibility and affordability of in-vitro fertilization treatments.
AI & Machine LearningDeep TechHealthtechMedical DevicesRobotics
Alan Murray(Founder & CEO)inAlejandro Chavez-Badiola, MD(Founder & Chief Medical Officer)Joshua Abram(Founder)in
Co-investorsACME CapitalAdvance Venture PartnersFuture Positive CapitalMuse CapitalTime BioVenturesACME
Delfina provides a pregnancy support app, including a "Delfina Doula" feature, that lets pregnant people share symptoms and health data such as blood pressure with their providers between appointments.
Digital HealthFemTechHealthtech
Co-investorsBread And Butter Ventures, LlcSemperVirens Venture CapitalStory VenturesUS Venture PartnersMetrodora VenturesTokio Marine Future Fund
HealthtechSan Francisco, US
Senan Ebrahim(Executive Officer, Director)Isabel Fulcher(Director)
BoardDafina Toncheva(Director)inJacob Yormak(Director)
Co-investorsBoutique Venture PartnersBread And Butter Ventures, LlcBread Butter VenturesGoodwater CapitalMetrodora VenturesSpringTime Ventures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.